<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03969433</url>
  </required_header>
  <id_info>
    <org_study_id>BEATLE</org_study_id>
    <nct_id>NCT03969433</nct_id>
  </id_info>
  <brief_title>Longitudinal Study for the Development of Innovative Wearable Tools for Foetal Wellbeing Monitoring</brief_title>
  <official_title>Longitudinal Study for the Development of Innovative Wearable Tools for Foetal Wellbeing Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bloom Technologies</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bloom Technologies</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to support the development of a new generation of the Bloomlife
      sensor, enabling continuous monitoring of foetal wellbeing.

      Data is collected in four Phases, with different experimental setups. Recordings with
      investigational and reference devices are performed on the subjects, at different gestational
      ages.

      The collected data is used for developing algorithms for the extraction of parameters
      descriptive of foetal wellbeing.

      Clinical information related to subjects' pregnancy and foetal health is also collected.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 5, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy and reliability in the detection of foetal heart rate</measure>
    <time_frame>Throughout the subject's participation in the study, from inclusion until delivery</time_frame>
    <description>Foetal heart rate is extracted from the collected electrophysiological data and compared to the reference</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Accuracy and reliability in the detection of foetal movements</measure>
    <time_frame>Throughout the subject's participation in the study, from inclusion until delivery</time_frame>
    <description>Foetal movements are detected from the collected sensor data and compared to the reference</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Foetal Wellbeing</condition>
  <arm_group>
    <arm_group_label>Phase I</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Data collections are performed with TMSi Porti system and CTG (reference)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phases II-III-IV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Data collections are performed with the Bloomlife sensor and CTG (reference)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TMSi Porti</intervention_name>
    <description>Data collections</description>
    <arm_group_label>Phase I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bloomlife sensor</intervention_name>
    <description>Data collections</description>
    <arm_group_label>Phases II-III-IV</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant

          -  Gestational age of at least 20 weeks

          -  Singleton pregnancy

          -  Willingness to participate in the study

        Exclusion Criteria:

          -  Multiple pregnancy

          -  Implanted pacemaker or any other implanted electrical device

          -  History of allergies to silicone-based adhesives
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wilfried Gyselaers, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ziekenhuis Oost-Limburg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elisa Rossetti, MS</last_name>
    <phone>+32483653848</phone>
    <email>elisa@bloom-life.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ziekenhuis Oost-Limburg</name>
      <address>
        <city>Genk</city>
        <state>Limburg</state>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hanne Marien, MS</last_name>
      <phone>089212032</phone>
      <phone_ext>+32</phone_ext>
      <email>Hanne.Marien@zol.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 28, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2019</study_first_posted>
  <last_update_submitted>February 12, 2020</last_update_submitted>
  <last_update_submitted_qc>February 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

